CL
CRCM LP
13F filer · CIK 0001483234Reported Aug 18, 2026
Net buyer this quarter
13F portfolio value$304MU.S. long equity reported on 13F
Positions136 new · 1 closed
Net flow last quarter+$179MBuys minus sells
Top 10 positions weight96.3%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 18, 202613 positions | |||||
| $198M | 65.25% | 0.32% | +110.2% | Q1 2024 | |
| $20.2M | 6.65% | 0.04% | Not reported | Q1 2024 | |
| $17.3M | 5.68% | 7.50% | New | Q2 2026 | |
| $14.9M | 4.89% | 18.17% | +101.4% | Q3 2025 | |
| $14M | 4.62% | 9.73% | +165.0% | Q4 2024 | |
| $13.6M | 4.47% | Not reported | New | Q2 2026 | |
| $5.6M | 1.84% | 0.48% | New | Q2 2026 | |
| $3.55M | 1.17% | 16.94% | +50.3% | Q4 2024 | |
| $3.3M | 1.09% | Not reported | +110.9% | Q3 2025 | |
| $2.12M | 0.70% | 2.18% | +67.3% | Q4 2025 | |
| $1.42M | 0.47% | 0.20% | New | Q2 2026 | |
| $174K | 0.06% | 0.14% | Not reported | Q3 2025 | |
| $32.9K | 0.01% | Not reported | New | Q2 2026 | |
| Q1 2026Reported May 13, 20268 positions | |||||
| $111M | 78.68% | 0.15% | +73.7% | Q1 2024 | |
| $14M | 9.91% | 9.92% | +15.3% | Q3 2025 | |
| $6.61M | 4.68% | 3.77% | +17.8% | Q4 2024 | |
| $4.6M | 3.26% | 11.27% | -42.6% | Q4 2024 | |
| $1.87M | 1.32% | 0.20% | New | Q1 2026 | |
| $1.55M | 1.10% | Not reported | -50.3% | Q3 2025 | |
| $1.28M | 0.90% | 1.30% | -72.3% | Q4 2025 | |
| $214K | 0.15% | 0.14% | -78.4% | Q3 2025 | |
| Q4 2025Reported Feb 13, 202611 positions | |||||
| $91.8M | 31.01% | 2.66% | -41.8% | Q2 2024 | |
| $58.4M | 19.74% | 0.09% | +83.3% | Q1 2024 | |
| $48.9M | 16.52% | 1.03% | +9.3% | Q2 2025 | |
| $43.2M | 14.61% | 0.06% | New | Q4 2025 | |
| ABRNAMAvidity Biosciences, Inc. | $14.6M | 4.93% | 0.13% | New | Q4 2025 |
| $12M | 4.07% | 8.65% | +373.2% | Q3 2025 | |
| $9.9M | 3.35% | 19.63% | +121.8% | Q4 2024 | |
| $6.94M | 2.34% | 3.27% | +154.2% | Q4 2024 | |
| $5.46M | 1.84% | 4.70% | New | Q4 2025 | |
| $3.11M | 1.05% | Not reported | Not reported | Q3 2025 | |
| $1.63M | 0.55% | 0.66% | +30.4% | Q3 2025 | |
| Q3 2025Reported Nov 14, 202510 positions | |||||
| $144M | 41.63% | 0.17% | +37.7% | Q1 2024 | |
| $109M | 31.52% | 5.10% | -49.5% | Q2 2024 | |
| $46.1M | 13.33% | 0.94% | +82.5% | Q2 2025 | |
| $28.6M | 8.27% | 0.05% | +40.1% | Q1 2024 | |
| $6.22M | 1.80% | 1.83% | New | Q3 2025 | |
| $3.15M | 0.91% | Not reported | New | Q3 2025 | |
| $2.64M | 0.76% | 0.51% | New | Q3 2025 | |
| $2.13M | 0.62% | 1.35% | +105.4% | Q4 2024 | |
| $2.09M | 0.60% | Not reported | Not reported | Q1 2025 | |
| $1.92M | 0.55% | 8.85% | +13.8% | Q4 2024 | |
Premium opens every quarter this fund has filed